These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

752 related articles for article (PubMed ID: 10799874)

  • 1. Differential requirement for p56lck in HIV-tat versus TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal kinase, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 2000 May; 164(10):5156-66. PubMed ID: 10799874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein tyrosine kinase p56lck is required for ceramide-induced but not tumor necrosis factor-induced activation of NF-kappa B, AP-1, JNK, and apoptosis.
    Manna SK; Sah NK; Aggarwal BB
    J Biol Chem; 2000 May; 275(18):13297-306. PubMed ID: 10788436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesnarinone suppresses TNF-induced activation of NF-kappa B, c-Jun kinase, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 2000 Jun; 164(11):5815-25. PubMed ID: 10820260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silymarin suppresses TNF-induced activation of NF-kappa B, c-Jun N-terminal kinase, and apoptosis.
    Manna SK; Mukhopadhyay A; Van NT; Aggarwal BB
    J Immunol; 1999 Dec; 163(12):6800-9. PubMed ID: 10586080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide suppresses TNF-induced cellular responses: effects on NF-kappa B, activator protein-1, c-Jun N-terminal protein kinase, and apoptosis.
    Manna SK; Mukhopadhyay A; Aggarwal BB
    J Immunol; 2000 Nov; 165(10):5962-9. PubMed ID: 11067959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation.
    Manna SK; Mukhopadhyay A; Aggarwal BB
    J Immunol; 2000 Jun; 164(12):6509-19. PubMed ID: 10843709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive leflunomide metabolite (A77 1726) blocks TNF-dependent nuclear factor-kappa B activation and gene expression.
    Manna SK; Aggarwal BB
    J Immunol; 1999 Feb; 162(4):2095-102. PubMed ID: 9973483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV type 1 glycoprotein 120 amplifies tumor necrosis factor-induced NF-kappa B activation in Jurkat cells.
    Shatrov VA; Ratter F; Gruber A; Dröge W; Lehmann V
    AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1209-16. PubMed ID: 8870842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-alpha suppresses activation of nuclear transcription factors NF-kappa B and activator protein 1 and potentiates TNF-induced apoptosis.
    Manna SK; Mukhopadhyay A; Aggarwal BB
    J Immunol; 2000 Nov; 165(9):4927-34. PubMed ID: 11046018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling through P2X7 receptor in human T cells involves p56lck, MAP kinases, and transcription factors AP-1 and NF-kappa B.
    Budagian V; Bulanova E; Brovko L; Orinska Z; Fayad R; Paus R; Bulfone-Paus S
    J Biol Chem; 2003 Jan; 278(3):1549-60. PubMed ID: 12424250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase.
    Manna SK; Sah NK; Newman RA; Cisneros A; Aggarwal BB
    Cancer Res; 2000 Jul; 60(14):3838-47. PubMed ID: 10919658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-Tat protein activates c-Jun N-terminal kinase and activator protein-1.
    Kumar A; Manna SK; Dhawan S; Aggarwal BB
    J Immunol; 1998 Jul; 161(2):776-81. PubMed ID: 9670954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thalidomide suppresses NF-kappa B activation induced by TNF and H2O2, but not that activated by ceramide, lipopolysaccharides, or phorbol ester.
    Majumdar S; Lamothe B; Aggarwal BB
    J Immunol; 2002 Mar; 168(6):2644-51. PubMed ID: 11884428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of tumor necrosis factor-activated nuclear transcription factor-kappaB, activator protein-1, c-Jun N-terminal kinase, and apoptosis by beta-lapachone.
    Manna SK; Gad YP; Mukhopadhyay A; Aggarwal BB
    Biochem Pharmacol; 1999 Apr; 57(7):763-74. PubMed ID: 10075082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-x(L) suppresses TNF-mediated apoptosis and activation of nuclear factor-kappaB, activation protein-1, and c-Jun N-terminal kinase.
    Manna SK; Haridas V; Aggarwal BB
    J Interferon Cytokine Res; 2000 Aug; 20(8):725-35. PubMed ID: 10954916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidants differentially regulate activation of nuclear factor-kappa B, activator protein-1, c-jun amino-terminal kinases, and apoptosis induced by tumor necrosis factor: evidence that JNK and NF-kappa B activation are not linked to apoptosis.
    Shrivastava A; Aggarwal BB
    Antioxid Redox Signal; 1999; 1(2):181-91. PubMed ID: 11228746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation-dependent activation of NF-kappa B. Requirement for p56 LCK and ZAP-70 protein tyrosine kinases.
    Livolsi A; Busuttil V; Imbert V; Abraham RT; Peyron JF
    Eur J Biochem; 2001 Mar; 268(5):1508-15. PubMed ID: 11231305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-Cell receptor signaling pathway exerts a negative control on thrombin-mediated increase in [Ca2+]i and p38 MAPK activation in Jurkat T cells: implication of the tyrosine kinase p56Lck.
    Maulon L; Guérin S; Ricci JE; Breittmayer DF; Auberger P
    Blood; 1998 Jun; 91(11):4232-41. PubMed ID: 9596671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of NF-kappa B activity by a membrane-transducing mutant of I kappa B alpha.
    Kabouridis PS; Hasan M; Newson J; Gilroy DW; Lawrence T
    J Immunol; 2002 Sep; 169(5):2587-93. PubMed ID: 12193729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.